KMTS
Kestra Medical Technologies, Ltd.
NasdaqGSUSDEQUITY
Healthcare
DELAYED
Last price
26.99
▼ 0.27 (0.99%)
MARKET · —
Price
Too many bars for candle bodies at this width — showing high/low range per bar. Zoom in or pick a shorter range.
Open
27.41
Prev close
27.26
Day high
27.46
Day low
26.34
Volume
508.75K
Market cap
$1.58B
P/E (TTM)
—
52W range
15.42 – 30.00
Insider net activity
Net shares
+272.74K
Net buying
Buy transactions
14
570.90K shares
Sell transactions
16
298.16K shares
Net transactions
+30
Buys less sells
Sell : buy shares
0.5 : 1
Mixed
Insider-held shares
3.11M
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Aug 17, 26 | WEBSTER BRIAN DANIEL Chief Executive Officer |
SELL | 15.00K | $412.18K | Direct |
| Aug 7, 26 | MAHBOOB VASEEM Chief Financial Officer |
SELL | 26.29K | $680.38K | Direct |
| Aug 4, 26 | FORD ALFRED J. JR Officer |
SELL | 6.28K | $151.14K | Direct |
| Aug 4, 26 | MAHBOOB VASEEM Chief Financial Officer |
SELL | 7.00K | $172.63K | Direct |
| Aug 4, 26 | WEBSTER BRIAN DANIEL Chief Executive Officer |
SELL | 51.90K | $1.27M | Direct |
| Aug 4, 26 | UMBERGER TRACI S General Counsel |
SELL | 3.58K | $86.07K | Direct |
| Aug 3, 26 | FORD ALFRED J. JR Officer |
SELL | 27.63K | $642.52K | Direct |
| Aug 3, 26 | MAHBOOB VASEEM Chief Financial Officer |
SELL | 18.19K | $418.22K | Direct |
| Aug 3, 26 | MORAN TIMOTHY P. Officer |
SELL | 15.26K | $348.31K | Direct |
| Aug 3, 26 | WEBSTER BRIAN DANIEL Chief Executive Officer |
SELL | 29.82K | $692.21K | Direct |
| Aug 3, 26 | UMBERGER TRACI S General Counsel |
SELL | 22.23K | $512.79K | Direct |
| Jul 16, 26 | MORAN TIMOTHY P. Officer |
STOCK | 39.11K | $0 | Direct |
| Jul 15, 26 | FORD ALFRED J. JR Officer |
STOCK | 58.83K | $0 | Direct |
| Jul 15, 26 | MAHBOOB VASEEM Chief Financial Officer |
STOCK | 44.12K | $0 | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
COHEN RAYMOND W |
Director | 50.90K | Purchase |
FORD ALFRED J. JR |
Officer | 99.56K | Sale |
HANLEY CONOR |
Director | 13.12K | Stock Award(Grant) |
KWO ELIZABETH |
Director | 10.91K | Stock Award(Grant) |
LADONE MARY KAY |
Director | 23.90K | Stock Award(Grant) |
MAHBOOB VASEEM |
Chief Financial Officer | 60.61K | Sale |
MORAN TIMOTHY P. |
Officer | 66.34K | Sale |
SCHWARTZ JEFFREY LAWRENCE |
Director and Beneficial Owner of more than 10% of a Class of Security | 27.03M | Stock Award(Grant) |
UMBERGER TRACI S |
General Counsel | 195.82K | Sale |
WEBSTER BRIAN DANIEL |
Chief Executive Officer | 460.21K | Sale |
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Options analytics
Put / call volume
—
—
Put / call open interest
—
Positioning, not flow
Max pain
—
—
ATM implied vol
—
Nearest strike to spot
Skew (10% OTM)
—
—
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
—
—
Heaviest put OI
—
—
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Trailing performance
Returnvs SPY
1W
-3.68%
-2.3%
1M
+25.13%
+21.4%
3M
+25.19%
+22.1%
6M
+1.62%
-9.4%
YTD
+1.77%
-10.5%
1Y
+62.59%
+42.6%
3Y
—
-74.2%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Fundamentals
Market cap$1.58B
Enterprise value$1.43B
Revenue (TTM)$95.13M
Gross profit$48.86M
EBITDA$-126.03M
Net income$-131.61M
EPS (TTM)$-2.43
Free cash flow$-75.76M
Total cash$196.43M
Total debt$46.79M
Book value / share$4.45
Shares outstanding58.60M
Float32.78M
Short % of float10.58%
Dividend yield—
Beta (5Y)—
Short interest
Shares short
3.29M
Prior 3.36M
Change vs prior
-2.0%
Shorts covering
% of float
10.58%
Elevated
% of shares out
5.62%
Against total outstanding
Days to cover
8.0
Crowded exit
Float
32.78M
Freely tradeable shares
Exchanges publish short interest twice a month with a settlement lag, so this is roughly two weeks behind. Days to cover divides shares short by average daily volume — it estimates how long covering would take, not whether it will happen.
Valuation & profitability ratios
Trailing P/E—
Forward P/E-13.36
PEG ratio—
Price / sales—
Price / book6.07
EV / revenue15.05
EV / EBITDA-11.36
Gross margin51.37%
Operating margin-137.38%
Profit margin-138.35%
Return on equity-56.60%
Return on assets-25.75%
Debt / equity18.02
Current ratio4.41
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2026 | 2025 | 2024 | 2023 | YoY |
|---|---|---|---|---|---|
| Total revenue | $95.13M | $59.81M | $27.81M | $7.63M | +59.0% |
| Operating revenue | $95.13M | $59.81M | $27.81M | $7.63M | +59.0% |
| Cost of revenue | $46.26M | $35.60M | $27.45M | $18.28M | +29.9% |
| Gross profit | $48.86M | $24.21M | $362.00K | -$10.65M | +101.8% |
| Research & development | $19.48M | $15.65M | $15.49M | $15.76M | +24.5% |
| Selling, general & admin | $164.12M | $114.94M | $69.94M | $54.01M | +42.8% |
| Total operating expense | $183.60M | $130.59M | $85.42M | $69.77M | +40.6% |
| Operating income | -$134.74M | -$106.38M | -$85.06M | -$80.42M | -26.7% |
| Net interest income | $805.00K | -$4.54M | -$6.23M | -$5.63M | +117.8% |
| Pre-tax income | -$131.32M | -$113.68M | -$94.10M | -$84.22M | -15.5% |
| Tax provision | $294.00K | $135.00K | $24.00K | $15.00K | +117.8% |
| Net income | -$131.61M | -$113.81M | -$94.12M | -$84.24M | -15.6% |
| Net income to common | -$131.61M | -$126.14M | -$100.84M | -$86.74M | -4.3% |
| Basic EPS | — | -5.13 | -5.07 | -4.36 | — |
| Diluted EPS | — | -5.13 | -5.07 | -4.36 | — |
| EBIT | -$123.77M | -$105.94M | -$87.87M | -$78.59M | -16.8% |
| EBITDA | -$115.06M | -$97.98M | -$76.31M | -$73.74M | -17.4% |
| Basic shares | — | 24.58M | 19.89M | 19.89M | — |
| Diluted shares | — | 24.58M | 19.89M | 19.89M | — |
| Line item | 2026 | 2025 | 2024 | 2023 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $99.71M | $237.59M | $8.25M | $14.81M | -58.0% |
| Cash & short-term investments | $196.43M | $237.59M | $8.25M | $14.81M | -17.3% |
| Accounts receivable | $14.54M | $8.08M | $2.00M | $0 | +80.0% |
| Inventory | $6.71M | $6.57M | $3.29M | $2.11M | +2.0% |
| Total current assets | $222.36M | $255.33M | $14.91M | $18.42M | -12.9% |
| Property, plant & equipment | $62.45M | $36.91M | $28.39M | $16.72M | +69.2% |
| Total assets | $358.46M | $295.74M | $45.95M | $38.66M | +21.2% |
| Total current liabilities | $50.37M | $37.98M | $32.97M | $36.74M | +32.6% |
| Current debt | — | — | — | $20.45M | — |
| Long-term debt | $42.65M | $41.10M | $42.54M | $17.32M | +3.8% |
| Total debt | $46.79M | $44.31M | $45.17M | $39.13M | +5.6% |
| Total liabilities | $98.81M | $90.34M | $255.33M | $156.23M | +9.4% |
| Retained earnings | -$651.86M | -$520.25M | -$406.44M | -$312.31M | -25.3% |
| Shareholder equity | $259.66M | $205.41M | -$209.38M | -$117.58M | +26.4% |
| Working capital | $171.99M | $217.35M | -$18.06M | -$18.32M | -20.9% |
| Net tangible assets | $259.66M | $205.41M | -$209.38M | -$117.58M | +26.4% |
| Shares issued | 58.38M | 51.35M | 49.53M | 49.53M | +13.7% |
| Line item | 2026 | 2025 | 2024 | 2023 | YoY |
|---|---|---|---|---|---|
| Net income | -$131.61M | -$113.81M | -$94.12M | -$84.24M | -15.6% |
| Depreciation & amortisation | $8.71M | $7.97M | $11.56M | $4.86M | +9.3% |
| Stock-based compensation | $33.64M | $24.27M | $1.49M | $1.21M | +38.6% |
| Change in working capital | $1.78M | -$6.20M | $3.89M | $1.30M | +128.6% |
| Operating cash flow | -$81.70M | -$77.61M | -$72.23M | -$69.64M | -5.3% |
| Capital expenditure | -$35.42M | -$23.59M | -$12.51M | -$15.46M | -50.1% |
| Investing cash flow | -$203.28M | -$23.31M | -$12.23M | -$15.46M | -772.1% |
| Dividends paid | -$323.00K | -$1.65M | -$799.00K | -$671.00K | +80.5% |
| Financing cash flow | $147.09M | $330.26M | $77.72M | $96.11M | -55.5% |
| Free cash flow | -$117.12M | -$101.20M | -$84.75M | -$85.10M | -15.7% |
| End cash position | $100.04M | $237.93M | $8.58M | $15.32M | -58.0% |
| Line item | 2026-04-30 | 2026-01-31 | 2025-10-31 | 2025-07-31 | 2025-04-30 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $28.64M | $24.55M | $22.57M | $19.37M | $17.23M | +16.6% |
| Operating revenue | $28.64M | $24.55M | $22.57M | $19.37M | $17.23M | +16.6% |
| Cost of revenue | $12.96M | $11.65M | $11.14M | $10.52M | $9.60M | +11.2% |
| Gross profit | $15.68M | $12.91M | $11.42M | $8.85M | $7.63M | +21.5% |
| Research & development | $5.63M | $4.97M | $4.88M | $4.00M | $5.39M | +13.3% |
| Selling, general & admin | $49.39M | $42.70M | $38.30M | $33.73M | $50.46M | +15.7% |
| Total operating expense | $55.03M | $47.67M | $43.18M | $37.73M | $55.84M | +15.4% |
| Operating income | -$39.34M | -$34.77M | -$31.75M | -$28.88M | -$48.21M | -13.2% |
| Net interest income | $382.00K | $275.00K | -$105.00K | $255.00K | -$104.00K | +38.9% |
| Pre-tax income | -$38.64M | -$34.13M | -$32.75M | -$25.79M | -$51.01M | -13.2% |
| Tax provision | $192.00K | $35.00K | $34.00K | $33.00K | $102.00K | +448.6% |
| Net income | -$38.84M | -$34.17M | -$32.78M | -$25.83M | -$52.05M | -13.7% |
| Net income to common | -$38.84M | -$34.17M | -$32.78M | -$25.83M | -$55.34M | -13.7% |
| Basic EPS | -0.67 | -0.61 | -0.64 | -0.50 | -2.21 | -9.8% |
| Diluted EPS | -0.67 | -0.61 | -0.64 | -0.50 | -2.21 | -9.8% |
| EBIT | -$36.80M | -$32.24M | -$30.85M | -$23.88M | -$49.25M | -14.1% |
| EBITDA | -$34.47M | -$30.26M | -$28.48M | -$21.85M | -$47.41M | -13.9% |
| Basic shares | 58.40M | 55.85M | 51.38M | 51.30M | 24.58M | +4.6% |
| Diluted shares | 58.40M | 55.85M | 51.38M | 51.30M | 24.58M | +4.6% |
| Line item | 2026-04-30 | 2026-01-31 | 2025-10-31 | 2025-07-31 | 2025-04-30 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $99.71M | $291.32M | $175.42M | $201.21M | $237.59M | -65.8% |
| Cash & short-term investments | $196.43M | $291.32M | $175.42M | $201.21M | $237.59M | -32.6% |
| Accounts receivable | $14.54M | $12.71M | $10.41M | $9.25M | $8.08M | +14.4% |
| Inventory | $6.71M | $6.83M | $6.92M | $6.80M | $6.57M | -1.8% |
| Total current assets | $222.36M | $314.06M | $195.41M | $220.69M | $255.33M | -29.2% |
| Property, plant & equipment | $62.45M | $57.22M | $47.89M | $42.42M | $36.91M | +9.2% |
| Total assets | $358.46M | $379.34M | $246.70M | $266.30M | $295.74M | -5.5% |
| Total current liabilities | $50.37M | $42.93M | $35.76M | $32.26M | $37.98M | +17.3% |
| Long-term debt | $42.65M | $42.26M | $41.87M | $41.49M | $41.10M | +0.9% |
| Total debt | $46.79M | $46.55M | $44.80M | $44.59M | $44.31M | +0.5% |
| Total liabilities | $98.81M | $91.35M | $82.62M | $82.14M | $90.34M | +8.2% |
| Retained earnings | -$651.86M | -$613.03M | -$578.86M | -$546.08M | -$520.25M | -6.3% |
| Shareholder equity | $259.66M | $287.99M | $164.08M | $184.16M | $205.41M | -9.8% |
| Working capital | $171.99M | $271.13M | $159.66M | $188.44M | $217.35M | -36.6% |
| Net tangible assets | $259.66M | $287.99M | $164.08M | $184.16M | $205.41M | -9.8% |
| Shares issued | 58.38M | 58.35M | 51.45M | 51.35M | 51.35M | +0.1% |
| Line item | 2026-04-30 | 2026-01-31 | 2025-10-31 | 2025-07-31 | 2025-04-30 | YoY |
|---|---|---|---|---|---|---|
| Net income | -$38.84M | -$34.17M | -$32.78M | -$25.83M | -$51.11M | -13.7% |
| Depreciation & amortisation | $2.33M | $1.98M | $2.37M | $2.03M | $1.84M | +17.2% |
| Stock-based compensation | $10.30M | $10.11M | $8.65M | $4.58M | $22.31M | +1.9% |
| Change in working capital | $4.93M | $2.12M | $711.00K | -$5.98M | -$3.46M | +133.0% |
| Operating cash flow | -$18.72M | -$18.37M | -$18.34M | -$26.27M | -$23.70M | -1.9% |
| Capital expenditure | -$9.66M | -$9.99M | -$7.50M | -$8.27M | -$8.04M | +3.2% |
| Investing cash flow | -$172.71M | -$14.92M | -$7.42M | -$8.23M | -$7.76M | -1,057.6% |
| Dividends paid | -$298.00K | -$25.00K | $0 | $0 | -$6.00K | -1,092.0% |
| Financing cash flow | -$185.00K | $149.18M | -$27.00K | -$1.88M | $214.70M | -100.1% |
| Free cash flow | -$28.39M | -$28.35M | -$25.84M | -$34.54M | -$31.74M | -0.1% |
| End cash position | $100.04M | $291.65M | $175.76M | $201.55M | $237.93M | -65.7% |
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Apr 2026 | -0.58 | -0.49 | +15.8% |
| Jan 2026 | -0.60 | -0.40 | +32.6% |
| Oct 2025 | -0.56 | -0.45 | +19.8% |
| Jul 2025 | -0.78 | -0.36 | +53.8% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | -0.62 | 3 | $29.01M | +49.8% |
| Next quarter | -0.61 | 3 | $31.52M | +39.7% |
| Current year | -2.31 | 3 | $137.06M | +44.1% |
| Next year | -2.07 | 3 | $193.81M | +41.4% |
Analyst targets & ownership
Mean target$30.00
High target$32.00
Low target$28.00
Implied upside11.15%
Analyst count7
ConsensusSTRONG BUY
Strong buy / Buy2 / 5
Hold1
Sell / Strong sell0 / 0
Held by insiders5.30%
Held by institutions103.36%
Institutions holding172
Price targets, consensus spread, insider and institutional ownership.
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 10, 26 | JP Morgan | INITIATED | — | Overweight |
| Jul 21, 26 | Oppenheimer | INITIATED | — | Perform |
| Jul 15, 26 | BTIG | MAINTAINED | Buy | Buy |
| Apr 9, 26 | Goldman Sachs | MAINTAINED | Neutral | Neutral |
| Apr 7, 26 | BTIG | MAINTAINED | Buy | Buy |
| Mar 25, 26 | BTIG | MAINTAINED | Buy | Buy |
| Mar 18, 26 | BTIG | MAINTAINED | Buy | Buy |
| Dec 15, 25 | Goldman Sachs | MAINTAINED | Neutral | Neutral |
| Dec 12, 25 | Wells Fargo | MAINTAINED | Overweight | Overweight |
| Dec 12, 25 | Piper Sandler | MAINTAINED | Overweight | Overweight |
| Nov 18, 25 | BTIG | INITIATED | — | Buy |
| Jul 17, 25 | Wells Fargo | MAINTAINED | Overweight | Overweight |
Moving averages & technicals
SMA 10
27.79
-2.89% from price
SMA 20
26.00
+3.81% from price
SMA 50
24.45
+10.40% from price
SMA 100
22.57
+19.57% from price
SMA 200
23.60
+14.39% from price
EMA 12
27.04
-0.18% from price
EMA 26
25.96
+3.98% from price
EMA 50
24.77
+8.97% from price
RSI (14)
56.8
Neutral
MACD (12,26,9)
1.08
Hist 0.03
ATR (14)
1.39
5.15% of price
Realised vol 30D
60.2%
Annualised
Bollinger upper
30.06
20, 2σ
Bollinger lower
21.94
20, 2σ
50 / 200 cross
Golden
24.45 vs 23.60
Trend bias
Above 200
+14.39%
Risk profile
Beta vs SPY
1.75
More volatile than market
Correlation to SPY
0.34
Loosely linked
Realised vol 30D
60.2%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-36.2%
Peak to trough
Max drawdown 5Y
-43.7%
Peak to trough
ATR 14
1.39
5.15% of price
Beta (reported)
—
5Y monthly, from filing
SEC filings
Proxy Statements
DEFA14A · 2026-07-28
Periodic Financial Reports
10-K · 2026-07-14
Offering Registrations
S-3ASR · 2026-04-01
Offering Registrations
S-8 · 2026-03-18
Corporate Changes & Voting Matters
8-K · 2026-03-17
Corporate Changes & Voting Matters
8-K · 2025-12-11
Corporate Changes & Voting Matters
8-K · 2025-12-04
Offering Registrations
S-1MEF · 2025-12-02
Headlines
Apple downgraded, HPE upgraded: Wall Street's top analyst calls
The Fly · 12d ago
KESTRA MEDICAL TECHNOLOGIES, LTD. Q4 2026 Earnings Call Summary
Moby · 38d ago
Kestra Medical Technologies Ltd (KMTS) Q4 2026 Earnings Call Highlights: Record Revenue Growth ...
GuruFocus.com · 39d ago
Kestra Medical Technologies Q4 Earnings Call Highlights
MarketBeat · 39d ago
Kestra Medical Technologies, Ltd. (KMTS) Reports Q4 Loss, Tops Revenue Estimates
Zacks · 39d ago
Kestra Medical Technologies Secures Up to $200 Million of Non-Dilutive Financing
GlobeNewswire · 39d ago
Kestra Medical Technologies Reports Fourth Quarter and Fiscal Year 2026 Financial Results
GlobeNewswire · 39d ago
Earnings To Watch: Kestra Medical Technologies Ltd (KMTS) Reports Q4 2026 Result
GuruFocus.com · 40d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.